HSBC on HCL Technologies
Maintained ‘Buy’ with a price target of Rs 650.
Core business should pick-up from Q4; products business unlikely to contribute much in near-term.
Balance sheet is healthy with industry lowest receivable days.
COVID-19 impact is a near-term risk but impact unlikely to be material.